| Term 
 | Definition 
 
        | 
focal in origin, often localized around a lesion within the brain   
simple=no loss of consciousness, may be sensory or motorcomplex=impairment or loss of consciounesssecondarily generalized=spreads to entire brain, often progresses to tonic-clonic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | global in origin neocortical electric discharges synchronize with those from the thalamus more likely to be congenital than lesion-associated   Absence: briefly impaired conscioussness ("zoning out spells") Myoclonic: shocklike muscle contractions Tonic: abrupt loss of muscle tone Tonic-Clonic: loss of muscle tone followed by spasms     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Seizure: finite episode of brain dysfunction resulting from abnormal neuronal discharge (often synchronous)   Epilepsy: group of chronic syndromes involving recurrent seizures |  | 
        |  | 
        
        | Term 
 
        |       General Principles of Antiseizure Pharmacology |  | Definition 
 
        | 1. Most patients respond positively to medications, but about 25% are refractory to pharmacologic aid   2.Type of seizure determines which drugs are potentially useful   3. Side effects are significant and additive, drug-drug interactions are common   4. All antiseizure medications block excessive neuronal firing, usually by blocking ion channels   5. Anticonvulsants stop convulsions (mostly older drugs) while antiepileptics prevent recurring seizures (many newer drugs)   6. generally good oral absorption and bioavailability followed by hepatic metabolism w/various CYP450s   7. multiple drugs may be needed to acheive seizure control |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: blocks voltage-gated Na+ channels Indications: Partial seizures and gen. tonic-clonics, mood stabilization in bipolar disorder, migraine prophylaxis Contraindicated: Absence seizures Toxicity: nystagmus, diploplia, ataxia, rash, hirsutism, gingival hyperplasia, facial "coarsening", teratogenic, drug interactions, sedation, variable bioavailability, anemia and leukopenia, cardiotoxicity from propylene glycol used in IV formulation Random: highly plasma protein bound, elimination shifts from first to zero order at high doses older highly effective drug, but largely replaced by less-sedating Diphenylhaydantoin orally or more water-soluble Fosphenytoin IV (no cardiotox.)   |  | 
        |  | 
        
        | Term 
 
        |       Phenytoin (Dilantin) Teratogenicity |  | Definition 
 
        | Fetal Hydantoin Syndrome   mental retardation abnormal facies: broad flat nasal ridge, epicanthal folds, hypertelorism, wide mouth, prominent upper lip hypoplastic distal phalanges |  | 
        |  | 
        
        | Term 
 
        |       Carbamazepine (Tegretol, Carbatrol) |  | Definition 
 
        | MOA: inhibits voltage-gated Na+ channels and potentiates GABA-A post-synaptic receptors Indicated for: partial and tonic-clonic seizures, mood stabilization in biopolar disorder Toxicity: diploplia, ataxia, rash, mild leukopenia, rare but potentially fatal aplastic anemia Effects on liver: potent CYP450 inducer! increases its own metabolism & that of other drugs over time Random: tricyclic antidepressant,  non-sedating, highly plasma protein bound |  | 
        |  | 
        
        | Term 
 
        |       Valproate (Valproic Acid, Depakote, Depakene) |  | Definition 
 
        | MOA: activates K+ channels to hyperpolarize membrane, inhibition of thalamic Ca2+ voltage-gated channels, inhibits Na+ channels and GABA transaminase  at high doses (usually too toxic to be useful) Useful for: all generalized seizures, esp. myoclonic, also a mood stabilizer (for bipolar disorder) and migraine prophylactic Toxicity: Nausea, epigastric distresss, hepatotoxicity rare but severe esp. if under 2 years old (monitor hepatic enzymes for first 4 months then sporadically), highly teratogenic Random: carboxylic acid, highly plasma protein bound, hepatic biotransformation to toxic compound |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: voltage-gated Na+ channel inhibitor, binds and potentiates postsynaptic GABA receptors, may also block glutamate receptors, multipart MOA increases effectiveness of drug (newer drug) Used for: partial seizures, tonic-clonic Toxicity: parasthesias, fatigue, decreased mental acuity, anxiety, confusion, glaucoma (must discontinue if vision changes occur!) Elimination: hepatic and renal (both organs must be functional!) newer drug   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: inhibits voltage-gated Na+ channels and thalamic calcium channels Indications: partial or tonic-clonic seizures (classified as broad spectrum in CNS notes) newer drug Adverse: dizziness, headache Toxicity: rashes, Stevens-Johnson syndrome/toxic epidermal necrolysis esp. in kids Elimination: hepatic glucuronidation (not safe for neonates!)   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: inhibits voltage-gated sodium and calcium channels Used as: adjunct tx for refractory partial seizures (classified as broad spectrum in CNS lecture) Adverse: somnolence and fatigue common, depression and psychosis less common Toxicity: severe skin rashes!, renal calculi |  | 
        |  | 
        
        | Term 
 
        |       Antiseizure medications that block voltage-gated Na+ channels |  | Definition 
 
        | Phenytoin Carbamazepine Valproate Topiramate Lamotrigine Zonisamide   dependant on frequency of neuronal discharge, therefore most useful in rapid-fire neurons |  | 
        |  | 
        
        | Term 
 
        |       Antiseizure meds. that increase GABA mediated Cl- flux |  | Definition 
 
        | Phenobarbital Primidone Tigabine Gabapentin Carbamazepine Valproate Topiramate Diazepam (and other benzodiazepines) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: enhances GABA mediated Cl- flux duration Used for: most seizure types, esp. good for partial and generalized Adverse: sedative activity typical since it is a barbiturate, tolerance, dependence Toxicity: respiratory depression, coma, death (rarely used now according to CNS notes) Random: one of the first antiseizure drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | metabolized by liver to Phenobarbital, a barbiturate (sedating, tolerance and dependence, respiratory depression)   very effective in infants with adequate liver function |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: inhibits GABA transporter reuptake, increasing synaptic GABA levels highly effecibe newer drug Adverse: Sedation at high doses Toxicity: generally well tolerated, tremor, anxiety, depression, psychosis (withdraw drug!) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: unclear--enchances presynaptic GABA concentrations, GABA analogue but doesn't activate receptors Uses: refractory partial seizures, neuropathic pain esp. postherpetic neuralgia & trigeminal neuralgia, newer drug Toxicity: well tolerated, sedation at high doses   Elimination: renal mostly in unchanged form--very little hepatic metabolism (safer for patients with liver compromise but more dangerous for those with kidney failure) |  | 
        |  | 
        
        | Term 
 
        |       Antiseizures meds. that block thalamic calcium channels |  | Definition 
 
        | Ethosuximide Valproate Lamotrigine Zonisamide   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: blockage of thalamic calcium channels   used ONLY for uncomplicated Absence seizures   highly effective and well tolerated   Adverse: gastric distress (N/V and anorexia), rash that starts like an insect bite but spreads esp. on face, blood dyscrasias   low clearance rates, relatively inactive metabolites |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | adjunct against partial seizures MOA unknown (this is widely used as a first line broad-spectrum antiseizure drug according to CNS notes)   Adverse: sedation and dizziness |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: blocks glutamate NMDA receptors   newer drug, adjunct for refractory partial seizures     Toxicity: aplastic anemia, hepatitis |  | 
        |  | 
        
        | Term 
 
        |     Drugs used to treat Simple Partial Seizures    (focal jerking/paresthesia/psychic symptoms/autonomic disfunction, no impairment of consciousness) |  | Definition 
 
        | newer: Levetiracetam, Tiagabine, and Zonisamide  Gabapentin, Lamotrigine Topiramate   older: Carbamazepine, Phenytoin, Valproate   low doses often effective |  | 
        |  | 
        
        | Term 
 
        |       Drugs used to treat Complex Partial Seizures   (impaired consciouness and focal signs)   |  | Definition 
 
        | newer: Gabapentin, Lamotrigine, Levetriacetam, Tigavine, Topiramate, Zonisamide   older: Carbamazepine, Phenytoin, Valproate |  | 
        |  | 
        
        | Term 
 
        |         Drugs used to treat Partial seizures with Secondary Generalization |  | Definition 
 
        | newer: Lamotrigine (limited by hepatotoxicity), Topiramate and Gabapentin (adjuntive drugs for refractory cases), Vigabatrin (alternative)   older: Carbamazipine, Phenytoin, and Valproate rapid first line drugs   Phenobarbital and Primidone alternative drugs in adults   Primidone is first line in infants |  | 
        |  | 
        
        | Term 
 
        |       Drugs used to treat Absence Seizures     (staring spells, automatisms, subtype of generalized) |  | Definition 
 
        | newer: Lamotrigine   older: Ethosuximide and Valproate preferred due to low sedation (valproate if concomitant tonic-clonic or myoclonic seizures present) Clonazepam   |  | 
        |  | 
        
        | Term 
 
        |       Drugs used to treat Myoclonic Seizures     (electric appearing muscle twitches, subtype of generalized) |  | Definition 
 
        | newer: Topiramate Levetiracetam, Lamotrigine, Zonisamide as back-up drugs Felbamate as adjunct (hematotoxic and hepatotoxic)   older: Valproate (first line), Clonazepam (limited by sedation) |  | 
        |  | 
        
        | Term 
 
        |       Drugs used to treat Tonic-Clonic Seizures     (collapse in tonic phase then twitching clonic phase, "grand mal" subtype of generalized) |  | Definition 
 
        | newer: Lamotrigine (limited by hepatotoxicity), Topiramate and Gabapentin (adjuntive drugs for refractory cases)   older: Carbamazipine, Phenytoin, and Valproate rapid first line drugs   Phenobarbital and Primidone alternative drugs in adults   Primidone is first line in infants |  | 
        |  | 
        
        | Term 
 
        |       Treatment of Status Epilepticus     (sustained seizure, most often tonic-clonic, >30 minute duration untreated, 30% mortality, severe muscle and brain damage possible) |  | Definition 
 
        | respiratory, cardiovascular, and metabolic supportive care   IV diazepam/lorazepam to terminate seizure, rectal diazepam (Diastat) is also used    followed by IV phenytoin (despite renal and cardiac toxicity due to propylene glycol in IV phenytoin) for long-term therapy (less sedating than benzodiazepines)   IV fosphenytoin (Cerebyx) is safter since it is formulated with water not propylene glycol   Phenobarbital may be used in children    General anesthesia as last resort in refractory cases     |  | 
        |  | 
        
        | Term 
 
        |       Benzodiazepines used to treat seizures |  | Definition 
 
        | Diazepam, Clonazepam, Clorazepate, Lorazepam, Nitrazepam   MOA: binds GABA A receptors and increases frequency of Cl- ion flux   used for absence, myoclonic and tonic-clonic seizures, IV or rectal forms (diazepam only) used to terminate status epilepticus    sedating, tolerance and dependence inducing, use limited by respiratory depression |  | 
        |  | 
        
        | Term 
 
        |       Barbiturate and Benzodiazepine Overdose/Toxicity |  | Definition 
 
        | life-threatening respiratory depression   Phenobarbital, Primidone, Diazepam, Clonazepam, Clorazepate, Lorazepam, Nitrazepam   supportive ventilatory care and flumazenil to treat |  | 
        |  | 
        
        | Term 
 
        |       Drug-drug interactions that increase antiseizure med. plasma levels |  | Definition 
 
        | cause increased toxicity   drugs that inhibit hepatic metabolism of the antiseizure meds. (H2 inhibitors and PPIs tend to do this)   drugs that displace plasma protein bound antiseizure meds. (like phenytoin) from albumin and other proteins |  | 
        |  | 
        
        | Term 
 
        |       Drug-drug interactions that lower plasma levels of antiseizure meds. |  | Definition 
 
        | cause increases in seizure frequency and severity   drugs that induce hepatic metabolism (like rifampin) |  | 
        |  | 
        
        | Term 
 
        |     Important Phenytoin Interactions |  | Definition 
 
        | phenobarbital, rifampin, and carbamazepine decrease plasma levels by inducing CYP450s   sulfonamides and valproic acid, increase levels by competing for plasma protein sites   cimetidine, proton pump inhibitors, and isoniazid increase levels by inhibiting hepatic metabolism |  | 
        |  | 
        
        | Term 
 
        |       Safer IV alternative to Phenytoin for status epilepticus |  | Definition 
 
        |     Fosphenytoin   metabolized to phenytoin but formulated without cardiotoxic propylene glycol |  | 
        |  | 
        
        | Term 
 
        |       Important Carbamazepine interactions |  | Definition 
 
        | carbamazepine is a self-inducer (dose must be raised as hepatic metabolism is upregulated)   propoxyphene and valproic acid increase levels by inhibiting hepatic metabolism |  | 
        |  | 
        
        | Term 
 
        |       Important Valproic Acid Interactions |  | Definition 
 
        | competes with phenytoin for albumin binding sites (increases free plasma levels of both)   metabolism inhibited by phenytoin, phenobarbital, lamotrigine   increases ethosuximide levels  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |  MOA: irreversible inhibitor of GABA transaminase (enzyme important in terminating GABA action)   newer antiseizure drug, very effective   Elimination: renal mostly in unchanged form--very little hepatic metabolism (safer for patients with liver compromise but more dangerous for those with kidney failure) |  | 
        |  | 
        
        | Term 
 
        |       Drugs that prolong Na+ channel inactivation at high, usually toxic, doses |  | Definition 
 
        | Phenobarbital   Valproic Acid |  | 
        |  | 
        
        | Term 
 
        |       Treatment of Infantile Spasms |  | Definition 
 
        | Corticotropin and cortiocsteroids-->Cushingoid effects   Benzodiazepines and other anticonvulsants (limited efficacy) |  | 
        |  | 
        
        | Term 
 
        |       Valproic Acid (Valproate) Teratogenicity |  | Definition 
 
        | neural tube defects   big problem   drug contraindicated in women with child-bearing potential unless no other medications effective in controlling seizures |  | 
        |  |